Huntington National Bank’s VivoSim Labs VIVS Stock Holding History

Huntington National Bank’s Portfolio VIVS Stock Details VIVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-63	Closed	-$833	–	4035
2023 Q4	$833	Buy	+63	New	+$936	﹤0.01%	2244

Other funds holding VIVS

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return

RJA

Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Huntington National Bank's VIVS Position: Q1 2024 in Review

Huntington National Bank sold out of VivoSim Labs (VIVS) in Q1 2024, closing a stake of 63 shares — an estimated $833 sold.

Huntington National Bank first reported a position in VIVS in Q4 2023 and held it in 1 quarter. The position peaked at $833 in Q4 2023. 31 funds tracked by Wall St. Rank hold VIVS as of Q1 2024.

Huntington National Bank reported no remaining VivoSim Labs position as of Q1 2024 after selling out during the quarter.
Huntington National Bank sold 63 VivoSim Labs shares in Q1 2024, an estimated $833.
Huntington National Bank first reported a position in VivoSim Labs in Q4 2023 and held it in 1 quarter.
Huntington National Bank's VivoSim Labs position peaked at $833 in Q4 2023.
31 funds tracked by Wall St. Rank held VivoSim Labs as of Q1 2024.

Based on Huntington National Bank's 13F filing for Q1 2024, filed 3 May 2024.